The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy

Autor: Almutairi, Malak, Gopal, Keshav, Greenwell, Amanda A., Young, Adrian, Gill, Robert, Aburasayn, Hanin, Al Batran, Rami, Chahade, Jadin J., Gandhi, Manoj, Eaton, Farah, Mailloux, Ryan J., Ussher, John R.
Zdroj: In Canadian Journal of Cardiology January 2021 37(1):140-150
Databáze: ScienceDirect
Externí odkaz: